Menu

Home / For Visitors / Exhibitor Product / ALA-4000, a sustained release apomorphine injectable for Parkinson's disease

ALA-4000, a sustained release apomorphine injectable for Parkinson's disease

Category: Pharmaceutical

Exhibitor: ALAR PHARMACEUTICALS INC.

Booth No: N604

Characteristic

ALA-4000 is a Alar self-developed long-acting injection for treating Parkinson's disease. Through steadily releasing therapeutic levels of apomorphine without dose dumping, ALA-4000 is anticipated to reduce the burden of drug administration, improving patients' medication adherence and convenience.

Other Products

Products you may be interested in

Highest Rated Products

TOP